A Turning point in Hepatology? EASL Reflects on the First Approved Drug for MASH. Francque S, Krag A, Shawcross DL, Zelber-Sagi S, et al. J Hepatol 2024 May 16:S0168-8278(24)00340-4. doi: 10.1016/j.jhep.2024.

Read + Share

Amedeo Smart

Independent Medical Education

Francque S, Krag A, Shawcross DL, Zelber-Sagi S, et al. A Turning point in Hepatology? EASL Reflects on the First Approved Drug for MASH. J Hepatol 2024 May 16:S0168-8278(24)00340-4. doi: 10.1016/j.jhep.2024.
PMID: 38762170